Concentrix share price today
Concentrix Corporation · CNXC · Technology · Information Technology Services · price as of the 4 November 2026 close, updated every trading day · results updated weekly · All US stock lists
Concentrix share price: $30.93 at the close on 4 November 2026, −11.0% in a year.
Concentrix Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.
The main question: the share price moved −11.0% in a year while yearly earnings per share moved −648.1%. The difference came from the market paying a higher multiple.
The price has been between phases. Over the last four quarters, results have been deteriorating, with profit −1,279.2% on a year earlier, and 199% of the last 3 years' profit came in as cash. What will decide it: whether earnings grow into a price that has already moved.
What is the Concentrix share price today?
Concentrix Corporation's share price was $30.93 at the close on 4 November 2026. That is 9.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between $22 and $44, and at that close it sat 40% of the way up from that low.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.
Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 11 weeks in a row.
Nov 2026: $30.93, 9.2% above its 200-day average.
- Price $30.93
- 50-day avg $28.71
- 200-day avg $28.33
| Week | Price | 50-day avg | 200-day avg |
|---|---|---|---|
| 11 Jul 2025 | $58.62 | – | – |
| 18 Jul 2025 | $58.33 | – | – |
| 25 Jul 2025 | $60.55 | – | – |
| 1 Aug 2025 | $46.22 | – | – |
| 8 Aug 2025 | $47.09 | – | – |
| 15 Aug 2025 | $48.19 | – | – |
| 22 Aug 2025 | $52.07 | – | – |
| 29 Aug 2025 | $52.76 | – | – |
| 5 Sep 2025 | $53.82 | – | – |
| 12 Sep 2025 | $53.97 | – | – |
| 19 Sep 2025 | $56.97 | $52.88 | – |
| 26 Sep 2025 | $47.66 | $52.58 | – |
| 3 Oct 2025 | $48.26 | $51.35 | – |
| 10 Oct 2025 | $44.78 | $50.37 | – |
| 17 Oct 2025 | $44.85 | $50.19 | – |
| 24 Oct 2025 | $46.93 | $50.12 | – |
| 31 Oct 2025 | $40.31 | $49.54 | – |
| 7 Nov 2025 | $34.76 | $48.22 | – |
| 14 Nov 2025 | $35.27 | $46.47 | – |
| 21 Nov 2025 | $35.63 | $44.52 | – |
| 28 Nov 2025 | $36.21 | $42.95 | – |
| 5 Dec 2025 | $37.61 | $41.08 | – |
| 12 Dec 2025 | $39.57 | $40.20 | – |
| 19 Dec 2025 | $41.61 | $39.41 | – |
| 26 Dec 2025 | $41.96 | $39.13 | – |
| 2 Jan 2026 | $41.21 | $38.83 | – |
| 9 Jan 2026 | $44.06 | $38.52 | – |
| 16 Jan 2026 | $43.15 | $38.60 | – |
| 23 Jan 2026 | $43.22 | $39.09 | – |
| 30 Jan 2026 | $37.35 | $39.53 | – |
| 6 Feb 2026 | $39.93 | $40.00 | – |
| 13 Feb 2026 | $30.39 | $39.86 | – |
| 20 Feb 2026 | $32.85 | $39.47 | – |
| 27 Feb 2026 | $32.80 | $38.70 | – |
| 6 Mar 2026 | $35.16 | $38.00 | – |
| 13 Mar 2026 | $31.67 | $37.10 | – |
| 20 Mar 2026 | $31.52 | $36.03 | – |
| 27 Mar 2026 | $26.42 | $34.62 | – |
| 2 Apr 2026 | $27.27 | $33.43 | – |
| 10 Apr 2026 | $26.12 | $32.03 | – |
| 17 Apr 2026 | $30.00 | $31.09 | – |
| 24 Apr 2026 | $26.17 | $30.12 | $41.53 |
| 1 May 2026 | $24.53 | $29.42 | $40.71 |
| 8 May 2026 | $24.27 | $28.70 | $39.83 |
| 15 May 2026 | $24.03 | $27.75 | $38.95 |
| 22 May 2026 | $26.34 | $26.93 | $38.38 |
| 29 May 2026 | $28.29 | $26.52 | $37.99 |
| 5 Jun 2026 | $27.82 | $26.42 | $37.49 |
| 12 Jun 2026 | $26.20 | $26.39 | $36.89 |
| 18 Jun 2026 | $25.08 | $26.25 | $36.38 |
| 26 Jun 2026 | $25.00 | $25.86 | $35.66 |
| 2 Jul 2026 | $23.60 | $25.38 | $35.07 |
| 10 Jul 2026 | $22.20 | $24.97 | $34.22 |
| 17 Jul 2026 | $24.43 | $25.02 | $33.53 |
| 24 Jul 2026 | $22.25 | $24.95 | $32.92 |
| 31 Jul 2026 | $24.60 | $25.10 | $32.39 |
| 7 Aug 2026 | $25.72 | $25.08 | $31.91 |
| 14 Aug 2026 | $24.49 | $24.76 | $31.36 |
| 21 Aug 2026 | $25.40 | $24.49 | $30.93 |
| 28 Aug 2026 | $29.38 | $24.65 | $30.71 |
| 4 Sep 2026 | $32.16 | $25.44 | $30.64 |
| 11 Sep 2026 | $28.24 | $25.71 | $30.52 |
| 18 Sep 2026 | $27.87 | $26.34 | $30.34 |
| 25 Sep 2026 | $27.08 | $26.81 | $30.13 |
| 2 Oct 2026 | $24.91 | $26.99 | $29.79 |
| 9 Oct 2026 | $25.95 | $27.12 | $29.43 |
| 16 Oct 2026 | $27.87 | $27.26 | $29.07 |
| 23 Oct 2026 | $33.00 | $27.83 | $28.78 |
| 30 Oct 2026 | $30.13 | $28.46 | $28.50 |
| 4 Nov 2026 | $30.93 | $28.71 | $28.33 |
Week by week since 2025: did it beat the S&P 500 over the past 13 weeks?
Ahead in 13 of 57 weeks
| Week | 13-week return vs S&P 500 |
|---|---|
| 11 Jul 2025 | no S&P 500 reading |
| 18 Jul 2025 | no S&P 500 reading |
| 25 Jul 2025 | no S&P 500 reading |
| 1 Aug 2025 | no S&P 500 reading |
| 8 Aug 2025 | no S&P 500 reading |
| 15 Aug 2025 | no S&P 500 reading |
| 22 Aug 2025 | no S&P 500 reading |
| 29 Aug 2025 | no S&P 500 reading |
| 5 Sep 2025 | no S&P 500 reading |
| 12 Sep 2025 | no S&P 500 reading |
| 19 Sep 2025 | no S&P 500 reading |
| 26 Sep 2025 | no S&P 500 reading |
| 3 Oct 2025 | no S&P 500 reading |
| 10 Oct 2025 | −28.3% |
| 17 Oct 2025 | −29.0% |
| 24 Oct 2025 | −28.8% |
| 31 Oct 2025 | −22.5% |
| 7 Nov 2025 | −31.5% |
| 14 Nov 2025 | −31.2% |
| 21 Nov 2025 | −33.7% |
| 28 Nov 2025 | −37.3% |
| 5 Dec 2025 | −36.1% |
| 12 Dec 2025 | −30.4% |
| 19 Dec 2025 | −29.5% |
| 26 Dec 2025 | −16.3% |
| 2 Jan 2026 | −16.7% |
| 9 Jan 2026 | −7.9% |
| 16 Jan 2026 | −7.9% |
| 23 Jan 2026 | −9.7% |
| 30 Jan 2026 | −8.8% |
| 6 Feb 2026 | +11.9% |
| 13 Feb 2026 | −15.3% |
| 20 Feb 2026 | −12.4% |
| 27 Feb 2026 | −9.8% |
| 6 Mar 2026 | −4.6% |
| 13 Mar 2026 | −17.1% |
| 20 Mar 2026 | −19.5% |
| 27 Mar 2026 | −28.9% |
| 2 Apr 2026 | −29.8% |
| 10 Apr 2026 | −38.6% |
| 17 Apr 2026 | −33.1% |
| 24 Apr 2026 | −43.0% |
| 1 May 2026 | −38.5% |
| 8 May 2026 | −46.0% |
| 15 May 2026 | −29.4% |
| 22 May 2026 | −28.0% |
| 29 May 2026 | −24.0% |
| 5 Jun 2026 | −30.6% |
| 12 Jun 2026 | −29.3% |
| 18 Jun 2026 | −35.6% |
| 26 Jun 2026 | −20.3% |
| 2 Jul 2026 | −27.0% |
| 10 Jul 2026 | −26.1% |
| 17 Jul 2026 | −23.2% |
| 24 Jul 2026 | −18.5% |
| 31 Jul 2026 | −3.4% |
| 7 Aug 2026 | +1.1% |
| 14 Aug 2026 | −3.1% |
| 21 Aug 2026 | −6.3% |
| 28 Aug 2026 | +2.2% |
| 4 Sep 2026 | +11.2% |
| 11 Sep 2026 | +4.7% |
| 18 Sep 2026 | +9.1% |
| 25 Sep 2026 | +2.5% |
| 2 Oct 2026 | +2.2% |
| 9 Oct 2026 | +13.8% |
| 16 Oct 2026 | +11.4% |
| 23 Oct 2026 | +45.5% |
| 30 Oct 2026 | +21.3% |
| 4 Nov 2026 | +21.1% |
Over the last 1 year the share price moved −47% while the S&P 500 moved +23%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What dividend does Concentrix pay?
Concentrix Corporation paid $1.44 per share over the last four reported quarters. The most recent declaration was $0.36 for Aug 2026. At today's price of $30.93 that is a yield of 4.66%, based on dividends already paid, not a forecast.
A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.
Dividend per share each quarter: latest $0.36 (Aug 2026)
- Dividend per share $0.36
| Quarter | Dividend per share |
|---|---|
| Nov 2023 | $0.30 |
| Feb 2024 | $0.30 |
| May 2024 | $0.30 |
| Aug 2024 | $0.30 |
| Nov 2024 | $0.33 |
| Feb 2025 | $0.33 |
| May 2025 | $0.33 |
| Aug 2025 | $0.33 |
| Nov 2025 | $0.36 |
| Feb 2026 | $0.36 |
| May 2026 | $0.36 |
| Aug 2026 | $0.36 |
Which stock lists is Concentrix on?
Concentrix is on one of our US lists: US tech stocks.
Is Concentrix profitable?
Concentrix Corporation posted a net loss of $989 M in the Aug 2026 quarter. The full FY25 year was a loss of $1.3 B. That loss is 40.3% of the quarter's revenue. The same quarter a year earlier earned $83.9 M. 2 of the last 12 reported quarters were loss-making.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
Aug 2026 profit was −$989 M, −1,279.2% on a year earlier. For the full year, FY25 profit was −$1.3 B (−630.8% on the year before).
FY25 profit −$1.3 B (−630.8% on the year before)
- Net profit −$1.3 B
| Quarter | Net profit |
|---|---|
| FY21 | $400 M |
| FY22 | $428 M |
| FY23 | $308 M |
| FY24 | $242 M |
| FY25 | −$1.3 B |
Growth on a year earlier
- Growth on a year earlier −630.8%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | 7.2% |
| FY23 | −28.1% |
| FY24 | −21.5% |
| FY25 | −630.8% |
Aug 2026: −$989 M (−1,279.2% on a year earlier)
- Net profit (quarterly) −$989 M
| Quarter | Net profit (quarterly) |
|---|---|
| Nov 2023 | $67.7 M |
| Feb 2024 | $50.1 M |
| May 2024 | $64.3 M |
| Aug 2024 | $16.1 M |
| Nov 2024 | $111 M |
| Feb 2025 | $66.8 M |
| May 2025 | $40.1 M |
| Aug 2025 | $83.9 M |
| Nov 2025 | −$1.5 B |
| Feb 2026 | $20.4 M |
| May 2026 | $54.1 M |
| Aug 2026 | −$989 M |
Growth on a year earlier
- Growth on a year earlier −1,279.2%
| Quarter | Growth on a year earlier |
|---|---|
| Nov 2023 | −34.4% |
| Feb 2024 | −42% |
| May 2024 | −17.1% |
| Aug 2024 | −78.9% |
| Nov 2024 | 64% |
| Feb 2025 | 33.4% |
| May 2025 | −37.7% |
| Aug 2025 | 422% |
| Nov 2025 | −1,427.5% |
| Feb 2026 | −69.5% |
| May 2026 | 35.1% |
| Aug 2026 | −1,279.2% |
Why profit moved: revenue changed −1.2% on a year earlier and the margin moved +1.3 percentage points. Sales did the work, and the margin was about flat.
On average over the last four quarters, profit changed −685.3% and revenue +2.6%. Profit is growing slower than sales: rising costs are taking part of the growth.
How much revenue does Concentrix make, and is it growing?
Concentrix Corporation reported $2.5 B of revenue in the Aug 2026 quarter, −1.2% on the same quarter a year earlier. Over 4 years it has grown 15.2% a year on average. The last full year, FY25, came in at $9.8 B. The last four reported quarters add to $10.0 B.
Revenue is everything the company billed its customers in the period.
FY25 revenue was $9.8 B, +2.2% on the year before.
FY25 revenue $9.8 B (+2.2% on the year before), 15.2% a year over 4 years
- Revenue $9.8 B
| Quarter | Revenue |
|---|---|
| FY21 | $5.6 B |
| FY22 | $6.3 B |
| FY23 | $7.1 B |
| FY24 | $9.6 B |
| FY25 | $9.8 B |
Growth on a year earlier
- Growth on a year earlier 2.2%
| Quarter | Growth on a year earlier |
|---|---|
| FY21 | – |
| FY22 | 13.2% |
| FY23 | 12.5% |
| FY24 | 35.2% |
| FY25 | 2.2% |
Aug 2026: $2.5 B (−1.2% on a year earlier)
- Revenue (quarterly) $2.5 B
| Quarter | Revenue (quarterly) |
|---|---|
| Nov 2023 | $2.2 B |
| Feb 2024 | $2.4 B |
| May 2024 | $2.4 B |
| Aug 2024 | $2.4 B |
| Nov 2024 | $2.4 B |
| Feb 2025 | $2.4 B |
| May 2025 | $2.4 B |
| Aug 2025 | $2.5 B |
| Nov 2025 | $2.6 B |
| Feb 2026 | $2.5 B |
| May 2026 | $2.5 B |
| Aug 2026 | $2.5 B |
Growth on a year earlier
- Growth on a year earlier −1.2%
| Quarter | Growth on a year earlier |
|---|---|
| Nov 2023 | 36% |
| Feb 2024 | 46.8% |
| May 2024 | 47.4% |
| Aug 2024 | 46.2% |
| Nov 2024 | 9.7% |
| Feb 2025 | −1.3% |
| May 2025 | 1.5% |
| Aug 2025 | 4% |
| Nov 2025 | 4.3% |
| Feb 2026 | 5.4% |
| May 2026 | 1.9% |
| Aug 2026 | −1.2% |
Recent pace: the last four quarters grew +2.6% on average, against 15.2% a year over the longer run, so this year is growing slower than its own long-run rate.
Is growth speeding up? Revenue over the last 12 months grew +2.6%, against +3.0% a year over the last 8 quarters (stabilising).
How much of every $100 of sales does Concentrix keep?
Concentrix Corporation's operating margin was 7.2% in the Aug 2026 quarter, 1.3 percentage points higher than the same quarter a year ago. Across 5 years it has been between 6.1% and 10.6%. The latest quarter is within that range.
Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed +1.3 percentage points on the year while gross margin changed +1.3 points. So the gain came mostly from the gross margin, which means input costs and prices charged.
FY25: 6.2%, within a range of 6.1% to 10.6% over 5 years
- Operating margin 6.2%
| Quarter | Operating margin |
|---|---|
| FY21 | 9.9% |
| FY22 | 10.6% |
| FY23 | 9.2% |
| FY24 | 6.1% |
| FY25 | 6.2% |
Change on the year before (points)
- Change on the year before (points) +0.1 pts
| Quarter | Change on the year before (points) |
|---|---|
| FY21 | – |
| FY22 | +0.7 pts |
| FY23 | −1.4 pts |
| FY24 | −3.1 pts |
| FY25 | +0.1 pts |
Aug 2026: operating margin 7.2% (+1.3 points on a year earlier)
- Operating margin 7.2%
| Quarter | Operating margin |
|---|---|
| Nov 2023 | 9.5% |
| Feb 2024 | 7.4% |
| May 2024 | 7.6% |
| Aug 2024 | 8% |
| Nov 2024 | 1.6% |
| Feb 2025 | 7.9% |
| May 2025 | 6.1% |
| Aug 2025 | 5.9% |
| Nov 2025 | 3.4% |
| Feb 2026 | 6.2% |
| May 2026 | 5.3% |
| Aug 2026 | 7.2% |
Change on a year earlier (points)
- Change on a year earlier (points) +1.3 pts
| Quarter | Change on a year earlier (points) |
|---|---|
| Nov 2023 | −2.1 pts |
| Feb 2024 | −2.6 pts |
| May 2024 | −3.0 pts |
| Aug 2024 | −3.1 pts |
| Nov 2024 | −7.9 pts |
| Feb 2025 | +0.5 pts |
| May 2025 | −1.5 pts |
| Aug 2025 | −2.1 pts |
| Nov 2025 | +1.8 pts |
| Feb 2026 | −1.7 pts |
| May 2026 | −0.8 pts |
| Aug 2026 | +1.3 pts |
Is Concentrix's profit turning into cash?
Over the last 3 years, 199% of Concentrix Corporation's reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $807 M of operating cash against −$1.3 B of profit. After $234 M of spending on assets, $572 M was left over as free cash.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
FY25: operating cash $807 M against profit −$1.3 B; 199% of 3 years' profit came in as cash
- Operating cash $807 M
- Net profit −$1.3 B
- Free cash $572 M
| Quarter | Operating cash | Net profit | Free cash |
|---|---|---|---|
| FY21 | $514 M | $400 M | $365 M |
| FY22 | $601 M | $428 M | $461 M |
| FY23 | $678 M | $308 M | $497 M |
| FY24 | $667 M | $242 M | $429 M |
| FY25 | $807 M | −$1.3 B | $572 M |
Aug 2026: operating cash $268 M
- Operating cash (quarterly) $268 M
| Quarter | Operating cash (quarterly) |
|---|---|
| Nov 2023 | $229 M |
| Feb 2024 | −$46.9 M |
| May 2024 | $238 M |
| Aug 2024 | $192 M |
| Nov 2024 | $284 M |
| Feb 2025 | $1.4 M |
| May 2025 | $237 M |
| Aug 2025 | $225 M |
| Nov 2025 | $344 M |
| Feb 2026 | −$83.2 M |
| May 2026 | $258 M |
| Aug 2026 | $268 M |
Operating cash as % of profit
- Operating cash as % of profit 477%
| Quarter | Operating cash as % of profit |
|---|---|
| Nov 2023 | 339% |
| Feb 2024 | −94% |
| May 2024 | 371% |
| Aug 2024 | 1,192% |
| Nov 2024 | 256% |
| Feb 2025 | 2% |
| May 2025 | 590% |
| Aug 2025 | 268% |
| Nov 2025 | – |
| Feb 2026 | −408% |
| May 2026 | 477% |
| Aug 2026 | – |
Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.
What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.
Where does Concentrix's cash go?
Concentrix Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $654 M on assets over the last 3 years. Averaged over those years that is 2.2% of FY25 revenue a year.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.
Spending on assets: $654 M over the last 3 years.
FY25: capex $234 M, steady spending
- Capex $234 M
| Quarter | Capex |
|---|---|
| FY21 | $149 M |
| FY22 | $140 M |
| FY23 | $181 M |
| FY24 | $239 M |
| FY25 | $234 M |
Aug 2026: capex $47.0 M in the quarter
- Capex (quarterly) $47.0 M
| Quarter | Capex (quarterly) |
|---|---|
| Nov 2023 | $64.8 M |
| Feb 2024 | $56.1 M |
| May 2024 | $60.1 M |
| Aug 2024 | $62.7 M |
| Nov 2024 | $59.9 M |
| Feb 2025 | $50.6 M |
| May 2025 | $55.8 M |
| Aug 2025 | $65.1 M |
| Nov 2025 | $63.0 M |
| Feb 2026 | $53.9 M |
| May 2026 | $48.2 M |
| Aug 2026 | $47.0 M |
Free cash
- Free cash $221 M
| Quarter | Free cash |
|---|---|
| Nov 2023 | $164 M |
| Feb 2024 | −$103 M |
| May 2024 | $178 M |
| Aug 2024 | $129 M |
| Nov 2024 | $225 M |
| Feb 2025 | −$49.2 M |
| May 2025 | $181 M |
| Aug 2025 | $160 M |
| Nov 2025 | $281 M |
| Feb 2026 | −$137 M |
| May 2026 | $210 M |
| Aug 2026 | $221 M |
In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it.
What is Concentrix's P/E ratio, and how does it compare with its own history?
Concentrix Corporation's P/E is 5.8×, with too little history to compare. Its usual P/E (the middle reading) is 8.9×, over 8 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.
P/E 5.8× against a usual 8.9×: with too little history to compare
- P/E 5.76×
- Median 8.86×
| Week | P/E | Median |
|---|---|---|
| 11 Jul 2025 | 16.1× | 8.86× |
| 18 Jul 2025 | 16.0× | 8.86× |
| 25 Jul 2025 | 16.6× | 8.86× |
| 1 Aug 2025 | 12.7× | 8.86× |
| 8 Aug 2025 | 12.9× | 8.86× |
| 15 Aug 2025 | 13.2× | 8.86× |
| 22 Aug 2025 | 14.3× | 8.86× |
| 29 Aug 2025 | 14.5× | 8.86× |
| 5 Sep 2025 | 11.4× | 8.86× |
| 12 Sep 2025 | 11.4× | 8.86× |
| 19 Sep 2025 | 12.0× | 8.86× |
| 26 Sep 2025 | 10.1× | 8.86× |
| 3 Oct 2025 | 10.2× | 8.86× |
| 10 Oct 2025 | 9.45× | 8.86× |
| 17 Oct 2025 | 9.47× | 8.86× |
| 24 Oct 2025 | 9.91× | 8.86× |
| 31 Oct 2025 | 8.51× | 8.86× |
| 7 Nov 2025 | 7.34× | 8.86× |
| 14 Nov 2025 | 7.44× | 8.86× |
| 21 Nov 2025 | 7.52× | 8.86× |
| 28 Nov 2025 | 7.64× | 8.86× |
| 5 Dec 2025 | 7.94× | 8.86× |
| 12 Dec 2025 | 8.35× | 8.86× |
| 19 Dec 2025 | 8.78× | 8.86× |
| 26 Dec 2025 | 8.86× | 8.86× |
| 2 Jan 2026 | 8.70× | 8.86× |
| 9 Jan 2026 | 9.30× | 8.86× |
| 16 Jan 2026 | 9.11× | 8.86× |
| 23 Jan 2026 | 9.12× | 8.86× |
| 30 Jan 2026 | 7.88× | 8.86× |
| 6 Feb 2026 | 8.43× | 8.86× |
| 13 Feb 2026 | 6.41× | 8.86× |
| 20 Feb 2026 | 6.93× | 8.86× |
| 27 Feb 2026 | 6.92× | 8.86× |
| 6 Mar 2026 | 7.42× | 8.86× |
| 13 Mar 2026 | 6.68× | 8.86× |
| 20 Mar 2026 | 6.65× | 8.86× |
| 27 Mar 2026 | 5.58× | 8.86× |
| 2 Apr 2026 | 5.76× | 8.86× |
Earnings per share, 12 months
- Earnings per share, 12 months $4.74
| Week | Earnings per share, 12 months |
|---|---|
| 11 Jul 2025 | – |
| 18 Jul 2025 | – |
| 25 Jul 2025 | – |
| 1 Aug 2025 | – |
| 8 Aug 2025 | – |
| 15 Aug 2025 | – |
| 22 Aug 2025 | – |
| 29 Aug 2025 | – |
| 5 Sep 2025 | – |
| 12 Sep 2025 | – |
| 19 Sep 2025 | – |
| 26 Sep 2025 | $4.74 |
| 3 Oct 2025 | $4.74 |
| 10 Oct 2025 | $4.74 |
| 17 Oct 2025 | $4.74 |
| 24 Oct 2025 | $4.74 |
| 31 Oct 2025 | $4.74 |
| 7 Nov 2025 | $4.74 |
| 14 Nov 2025 | $4.74 |
| 21 Nov 2025 | $4.74 |
| 28 Nov 2025 | $4.74 |
| 5 Dec 2025 | $4.74 |
| 12 Dec 2025 | $4.74 |
| 19 Dec 2025 | $4.74 |
| 26 Dec 2025 | $4.74 |
| 2 Jan 2026 | $4.74 |
| 9 Jan 2026 | $4.74 |
| 16 Jan 2026 | $4.74 |
| 23 Jan 2026 | $4.74 |
| 30 Jan 2026 | $4.74 |
| 6 Feb 2026 | $4.74 |
| 13 Feb 2026 | $4.74 |
| 20 Feb 2026 | $4.74 |
| 27 Feb 2026 | $4.74 |
| 6 Mar 2026 | $4.74 |
| 13 Mar 2026 | $4.74 |
| 20 Mar 2026 | $4.74 |
| 27 Mar 2026 | $4.74 |
| 2 Apr 2026 | $4.74 |
PEG 0.46 at the Aug 2026 quarter end: below 1.0, so the P/E is smaller than the earnings growth rate
- PEG 0.46×
- PEG = 1.0 1.00×
| Quarter | PEG | PEG = 1.0 |
|---|---|---|
| Nov 2021 | 0.74× | 1.00× |
| Feb 2022 | 0.81× | 1.00× |
| May 2022 | 0.61× | 1.00× |
| Aug 2022 | 0.74× | 1.00× |
| Nov 2022 | 0.94× | 1.00× |
| Feb 2023 | 1.24× | 1.00× |
| May 2023 | 0.69× | 1.00× |
| Aug 2023 | 0.85× | 1.00× |
| Nov 2023 | 0.76× | 1.00× |
| Feb 2024 | 0.72× | 1.00× |
| May 2024 | 0.63× | 1.00× |
| Aug 2024 | 0.68× | 1.00× |
| Nov 2024 | 0.51× | 1.00× |
| Feb 2025 | 0.56× | 1.00× |
| May 2025 | 0.62× | 1.00× |
| Aug 2025 | 0.60× | 1.00× |
| Nov 2025 | 0.47× | 1.00× |
| Feb 2026 | 0.33× | 1.00× |
| May 2026 | 0.30× | 1.00× |
| Aug 2026 | 0.46× | 1.00× |
Why the multiple is where it is: over the past year earnings per share moved −648.1% while the price moved −11.0%. The price did better than earnings, which pushed the multiple up within its own range.
In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple.
Is the Concentrix business getting better or worse?
Concentrix Corporation's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE steady at 5.0%; each line tells part of the story. This is based on 12 quarters of 4 measures.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Growth year by year: revenue +2.2% in FY25, profit −630.8%
- Revenue growth 2.2%
| Quarter | Revenue growth |
|---|---|
| FY21 | – |
| FY22 | 13.2% |
| FY23 | 12.5% |
| FY24 | 35.2% |
| FY25 | 2.2% |
Profit growth, EPS growth
- Profit growth −300%
- EPS growth −300%
| Quarter | Profit growth | EPS growth |
|---|---|---|
| FY21 | – | – |
| FY22 | 7.2% | 7.5% |
| FY23 | −28.1% | −31.2% |
| FY24 | −21.5% | −34.8% |
| FY25 | −300% | −300% |
Three growth lines over twelve quarters: revenue stabilising
- Revenue 2.6%
| Quarter | Revenue |
|---|---|
| Nov 2023 | 12.5% |
| Feb 2024 | 22.7% |
| May 2024 | 33.6% |
| Aug 2024 | 44.1% |
| Nov 2024 | 35.2% |
| Feb 2025 | 21.7% |
| May 2025 | 11.3% |
| Aug 2025 | 3.4% |
| Nov 2025 | 2.2% |
| Feb 2026 | 3.8% |
| May 2026 | 3.9% |
| Aug 2026 | 2.6% |
Profit, EPS
- Profit −300%
- EPS −300%
| Quarter | Profit | EPS |
|---|---|---|
| Nov 2023 | −28.1% | −30.3% |
| Feb 2024 | −33.1% | −38.3% |
| May 2024 | −30.6% | −40.1% |
| Aug 2024 | −42.3% | −53.8% |
| Nov 2024 | −21.6% | −35.5% |
| Feb 2025 | −4.9% | −17.6% |
| May 2025 | −9.4% | −15.7% |
| Aug 2025 | 52.3% | 53.5% |
| Nov 2025 | −300% | −300% |
| Feb 2026 | −300% | −300% |
| May 2026 | −300% | −300% |
| Aug 2026 | −300% | −300% |
ROCE: the return line, worked out each quarter
- ROCE 5%
| Quarter | ROCE |
|---|---|
| Nov 2023 | 9.1% |
| Feb 2024 | 9.2% |
| May 2024 | 9.5% |
| Aug 2024 | 8.6% |
| Nov 2024 | 5.8% |
| Feb 2025 | 5.8% |
| May 2025 | 5.5% |
| Aug 2025 | 5% |
| Nov 2025 | – |
| Feb 2026 | – |
| May 2026 | – |
| Aug 2026 | – |
Why it matters: when the lines disagree, each line above matters more than any single label.
The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | +2.2% | +15.8% | — | — |
| Stock price | −11.0% | — | — | — |
How much does Concentrix earn on its capital?
Concentrix Corporation earned a ROE of −47% in FY25. Its return on capital used (ROIC) is 3.3 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a −13.1% net margin and 0.91× asset turnover (sales divided by assets).
Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.
Why the return is what it is (FY25): a −13.1% net margin × 0.91× asset turnover × 3.92× leverage (assets divided by equity) ≈ −46.7% on equity. The margin does its share; borrowing is a big part of it.
The key test, return on capital used minus the cost of capital: 8.2% − 4.9% = +3.3 percentage points. The 4.9% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.
The 8.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 7.0%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.
FY25: ROE −47%, the full history
- ROE −46.8%
- ROIC (annual) 7%
- Cost of capital 4.9%
| Quarter | ROE | ROIC (annual) | Cost of capital |
|---|---|---|---|
| FY21 | 15.3% | 10.7% | 4.9% |
| FY22 | 15.9% | 10.7% | 4.9% |
| FY23 | 7.4% | 6.8% | 4.9% |
| FY24 | 6% | 5.2% | 4.9% |
| FY25 | −46.8% | 7% | 4.9% |
Aug 2026: ROIC 4.9% (last 12 months) against a 4.9% cost of capital
- ROIC (12 months) 4.9%
- ROE (12 months) 8.1%
- Cost of capital 4.9%
| Quarter | ROIC (12 months) | ROE (12 months) | Cost of capital |
|---|---|---|---|
| Nov 2023 | 9.5% | 10.8% | 4.9% |
| Feb 2024 | 9.8% | 7.9% | 4.9% |
| May 2024 | 8.8% | 5.1% | 4.9% |
| Aug 2024 | 7.8% | 6.5% | 4.9% |
| Nov 2024 | 6.5% | 1.6% | 4.9% |
| Feb 2025 | 4.3% | 11.3% | 4.9% |
| May 2025 | 4.4% | 7% | 4.9% |
| Aug 2025 | 4.3% | 4.1% | 4.9% |
| Nov 2025 | 4.3% | 8.2% | 4.9% |
| Feb 2026 | 4.9% | −167% | 4.9% |
| May 2026 | 4.9% | 3.1% | 4.9% |
| Aug 2026 | 4.9% | 8.1% | 4.9% |
Does Concentrix have too much debt?
Concentrix Corporation has total debt of $5.3 B against shareholder equity of $1.8 B as of Aug 2026, so its debt is 2.99× its equity. Year by year, that ratio went from 0.50 in FY21 to 2.02 in FY25. Keep that borrowing in mind when reading the returns on this page.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
FY25: debt $5.5 B, 2.02× equity
- Total debt $5.5 B
| Quarter | Total debt |
|---|---|
| FY21 | $1.3 B |
| FY22 | $2.7 B |
| FY23 | $5.8 B |
| FY24 | $5.6 B |
| FY25 | $5.5 B |
Debt-to-equity
- Debt-to-equity 2.02×
| Quarter | Debt-to-equity |
|---|---|
| FY21 | 0.50× |
| FY22 | 1.01× |
| FY23 | 1.40× |
| FY24 | 1.39× |
| FY25 | 2.02× |
Aug 2026: debt $5.3 B, debt-to-equity 2.99
- Total debt (quarterly) $5.3 B
| Quarter | Total debt (quarterly) |
|---|---|
| Nov 2023 | $5.8 B |
| Feb 2024 | $5.9 B |
| May 2024 | $5.8 B |
| Aug 2024 | $5.8 B |
| Nov 2024 | $5.6 B |
| Feb 2025 | $5.7 B |
| May 2025 | $5.8 B |
| Aug 2025 | $5.7 B |
| Nov 2025 | $5.5 B |
| Feb 2026 | $5.7 B |
| May 2026 | $5.5 B |
| Aug 2026 | $5.3 B |
Debt-to-equity
- Debt-to-equity 2.99×
| Quarter | Debt-to-equity |
|---|---|
| Nov 2023 | 1.40× |
| Feb 2024 | 1.45× |
| May 2024 | 1.42× |
| Aug 2024 | 1.39× |
| Nov 2024 | 1.39× |
| Feb 2025 | 1.42× |
| May 2025 | 1.36× |
| Aug 2025 | 1.32× |
| Nov 2025 | 2.02× |
| Feb 2026 | 2.04× |
| May 2026 | 2.04× |
| Aug 2026 | 2.99× |
What is the Concentrix shareholding pattern?
16.5% of Concentrix Corporation's tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 4.1 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.
There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.
It is a single reading at one point in time; we do not have its history.
Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.
How far is Concentrix from balance-sheet trouble?
For Concentrix Corporation, the Z-score is 1.36. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
Why it matters: a Z-score of 1.36 is inside the danger zone, so the balance sheet is a real risk.
How does Concentrix rank in its industry?
43.5 out of 100, rank 18 of 28 in Information Technology Services, with 75% of the evidence available.
Concentrix Corporation scores 43.5 out of 100 against the 28 companies it is compared with in Information Technology Services, ranking 18. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 15.2 + 7.8 + 11.3 + 9.2 = 43.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Concentrix compared with?
Concentrix ranks 18 of 28 Information Technology Services companies on the 4-Factor Sector Score, with 43.5 out of 100.
- 1Gartner, Inc.IT · breaking out · Most evidence points up · 81% evidence70.4out of 100
How the score adds up
Growth & earnings 19.3/35 · Revenue 0.7% · Profit -38.9% · Operating margin change 3.2 points · 83% evidenceCapital efficiency 20.6/25 · ROCE 35.7% · Operating margin 22.6% · 76% evidenceValuation 14.6/20 · P/E 11.2× · PEG 0.45 · 65% evidenceRelative strength 15.9/20 · Lead over its industry 9.1% · Lead over S&P 500 5.9% · 1 year -10.1% · 100% evidence · 12 of 12 weeks aheadExact sum: 19.3 + 20.6 + 14.6 + 15.9 = 70.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 2Accenture plcACN · breaking out · Most evidence points up · 85% evidence70.0out of 100
How the score adds up
Growth & earnings 19.6/35 · Revenue 6.5% · Profit 9% · Operating margin change 2.6 points · 95% evidenceCapital efficiency 19.3/25 · ROCE 23.7% · Operating margin 17.8% · 76% evidenceValuation 11.9/20 · P/E 13.9× · PEG 1.19 · 65% evidenceRelative strength 19.2/20 · Lead over its industry 23.2% · Lead over S&P 500 19.2% · 1 year 7.6% · 100% evidence · 8 of 12 weeks aheadExact sum: 19.6 + 19.3 + 11.9 + 19.2 = 70 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 3ExlService Holdings, Inc.EXLS · breaking out · Most evidence points up · 81% evidence67.7out of 100
How the score adds up
Growth & earnings 21.5/35 · Revenue 13.7% · Profit 5.5% · Operating margin change -1.2 points · 83% evidenceCapital efficiency 19.1/25 · ROCE 31.8% · Operating margin 14.6% · 76% evidenceValuation 9.4/20 · P/E 15.8× · PEG 1.63 · 65% evidenceRelative strength 17.7/20 · Lead over its industry 19.9% · Lead over S&P 500 17% · 1 year 9.1% · 100% evidence · 12 of 12 weeks aheadExact sum: 21.5 + 19.1 + 9.4 + 17.7 = 67.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4Broadridge Financial Solutions, Inc.BR · breaking out · Most evidence points up · 81% evidence65.0out of 100
How the score adds up
Growth & earnings 20.6/35 · Revenue 8.5% · Profit 34% · Operating margin change 0.5 points · 83% evidenceCapital efficiency 17.2/25 · ROCE 17.3% · Operating margin 24.6% · 76% evidenceValuation 14.5/20 · P/E 14.1× · PEG 0.4 · 65% evidenceRelative strength 12.7/20 · Lead over its industry 2.5% · Lead over S&P 500 -0.4% · 1 year -14.6% · 100% evidence · 12 of 12 weeks aheadExact sum: 20.6 + 17.2 + 14.5 + 12.7 = 65 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 5Penguin Solutions, Inc.PENG · quiet · Evidence leans up · 75% evidence62.4out of 100
How the score adds up
Growth & earnings 30.8/35 · Revenue 26.5% · Profit 100% · Operating margin change 7.4 points · 95% evidenceCapital efficiency 10.3/25 · ROCE 11.3% · Operating margin 13.4% · 76% evidenceValuation 9.1/20 · P/E 16.8× · PEG — · 15% evidenceRelative strength 12.2/20 · Lead over its industry 13.3% · Lead over S&P 500 17% · 1 year 122.9% · 100% evidence · 0 of 12 weeks aheadExact sum: 30.8 + 10.3 + 9.1 + 12.2 = 62.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 6Jack Henry & Associates, Inc.JKHY · turning · Evidence leans up · 81% evidence61.9out of 100
How the score adds up
Growth & earnings 18.2/35 · Revenue 7.1% · Profit 10.3% · Operating margin change -2.8 points · 83% evidenceCapital efficiency 20.0/25 · ROCE 24.8% · Operating margin 22.5% · 76% evidenceValuation 8.6/20 · P/E 19.5× · PEG 1.66 · 65% evidenceRelative strength 15.1/20 · Lead over its industry 7.1% · Lead over S&P 500 4.8% · 1 year 11.4% · 100% evidence · 7 of 12 weeks aheadExact sum: 18.2 + 20 + 8.6 + 15.1 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7Genpact LimitedG · breaking out · Evidence leans up · 81% evidence61.9out of 100
How the score adds up
Growth & earnings 16.6/35 · Revenue 6.5% · Profit 8.2% · Operating margin change 0.1 points · 83% evidenceCapital efficiency 16.5/25 · ROCE 18.3% · Operating margin 15% · 76% evidenceValuation 14.8/20 · P/E 8× · PEG 0.67 · 65% evidenceRelative strength 14.0/20 · Lead over its industry 4% · Lead over S&P 500 1% · 1 year -8.3% · 100% evidence · 12 of 12 weeks aheadExact sum: 16.6 + 16.5 + 14.8 + 14 = 61.9 · What this means: Relative strength against the index is 1%, and revenue and profit growth are weak. - 8Cognizant Technology Solutions CorporationCTSH · breaking out · Evidence leans up · 81% evidence58.5out of 100
How the score adds up
Growth & earnings 17.2/35 · Revenue 5.6% · Profit -8.9% · Operating margin change 1.9 points · 83% evidenceCapital efficiency 18.4/25 · ROCE 20.3% · Operating margin 17.5% · 76% evidenceValuation 12.4/20 · P/E 8.3× · PEG 1.31 · 65% evidenceRelative strength 10.5/20 · Lead over its industry 0.3% · Lead over S&P 500 -3% · 1 year -10.1% · 100% evidence · 12 of 12 weeks aheadExact sum: 17.2 + 18.4 + 12.4 + 10.5 = 58.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 9CGI Inc.GIB · breaking out · Evidence leans up · 81% evidence58.0out of 100
How the score adds up
Growth & earnings 16.8/35 · Revenue 5.7% · Profit 1.1% · Operating margin change -0.1 points · 83% evidenceCapital efficiency 17.1/25 · ROCE 18.9% · Operating margin 16.2% · 76% evidenceValuation 10.8/20 · P/E 11.1× · PEG 1.6 · 65% evidenceRelative strength 13.3/20 · Lead over its industry 3.6% · Lead over S&P 500 1.1% · 1 year -4.5% · 100% evidence · 8 of 12 weeks aheadExact sum: 16.8 + 17.1 + 10.8 + 13.3 = 58 · What this means: Relative strength against the index is 1.1%, and revenue and profit growth are weak. - 10Ingram Micro Holding CorporationINGM · quiet · Evidence leans up · 81% evidence57.0out of 100
How the score adds up
Growth & earnings 25.5/35 · Revenue 11.5% · Profit 61% · Operating margin change 0.2 points · 83% evidenceCapital efficiency 12.2/25 · ROCE 14.7% · Operating margin 1.7% · 76% evidenceValuation 14.6/20 · P/E 14.7× · PEG 0.26 · 65% evidenceRelative strength 4.7/20 · Lead over its industry -3.2% · Lead over S&P 500 -3.3% · 1 year 19.3% · 100% evidence · 1 of 12 weeks aheadExact sum: 25.5 + 12.2 + 14.6 + 4.7 = 57 · What this means: Earnings are strong; relative strength in its sector is -3.2% and the one-year return is 19.3%. - 11Science Applications International CorporationSAIC · leader · Evidence leans up · 85% evidence55.8out of 100
- 12NIQ Global Intelligence plcNIQ · leader · Evidence leans up · 61% evidence54.6out of 100
- 13CDW CorporationCDW · turning · Evidence leans up · 81% evidence53.9out of 100
- 14EPAM Systems, Inc.EPAM · breaking out · Evidence leans up · 81% evidence52.3out of 100
- 15Infosys LimitedINFY · basing · Evidence leans down · 85% evidence49.9out of 100
- 16International Business Machines CorporationIBM · turning · Evidence leans down · 85% evidence49.2out of 100
- 17Wise Group plcWSE · basing · Evidence leans down · 66% evidence44.3out of 100
- 18Concentrix Corporation this pageCNXC · breaking out · Evidence leans down · 75% evidence43.5out of 100
How the score adds up
Growth & earnings 15.2/35 · Revenue 2.6% · Profit -891.1% · Operating margin change 1.3 points · 95% evidenceCapital efficiency 7.8/25 · ROCE 8% · Operating margin 7.2% · 76% evidenceValuation 11.3/20 · P/E -1.3× · PEG — · 15% evidenceRelative strength 9.2/20 · Lead over its industry -2.6% · Lead over S&P 500 -5.8% · 1 year -11% · 100% evidence · 7 of 12 weeks aheadExact sum: 15.2 + 7.8 + 11.3 + 9.2 = 43.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 19CACI International IncCACI · quiet · Evidence leans down · 85% evidence43.2out of 100
- 20Globant S.A.GLOB · breaking out · Evidence leans down · 74% evidence42.2out of 100
- 21Pony AI Inc.PONY · quiet · Evidence leans down · 64% evidence41.6out of 100
- 22Leidos Holdings, Inc.LDOS · quiet · Too little evidence to rank firmly · 58% evidence41.6out of 100
- 23Kyndryl Holdings, Inc.KD · turning · Evidence leans down · 71% evidence39.6out of 100
- 24DXC Technology CompanyDXC · breaking out · Evidence leans down · 71% evidence39.4out of 100
- 25Fidelity National Information Services, Inc.FIS · quiet · Evidence leans down · 64% evidence37.8out of 100
- 26Cipher Digital Inc.CIFR · quiet · Most evidence points down · 64% evidence34.6out of 100
- 27Applied Digital CorporationAPLD · quiet · Too little evidence to rank firmly · 55% evidence30.0out of 100
- 28Parsons CorporationPSN · turning · Most evidence points down · 81% evidence23.6out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Information Technology Services, all 28 compared on one page.
Which companies are close to Concentrix in size?
Concentrix is the 30th largest of 52 Information Technology Services companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: DXC Technology Company, Globant S.A. and Pony AI Inc. Just below it: ChronoScale Holdings Corporation, Formula Systems (1985) and Mega Fortune Company.
Information Technology Services companies close in size
- DXC Technology Company $2.3 billion
- Globant S.A. $2.1 billion
- Pony AI Inc. $2.1 billion
- Concentrix Corporation $1.9 billion
- ChronoScale Holdings Corporation $1.8 billion
- Formula Systems (1985) Ltd. $1.7 billion
- Mega Fortune Company Limited $1.6 billion
All 52 Information Technology Services companies, largest first
Companies close in size in other industries
- Tecnoglass Inc. $1.9 billion · Building Materials
- Centrus Energy Corp. $1.9 billion · Uranium
- Concentrix Corporation $1.9 billion
- BioLife Solutions, Inc. $1.9 billion · Medical Instruments & Supplies
- eToro Group Ltd. $1.9 billion · Capital Markets
What else do people ask about Concentrix?
What were Concentrix's latest quarterly results?
Concentrix Corporation reported revenue of $2.5 B and a net loss of $989 M for the Aug 2026 quarter. Revenue fell 1.2% and profit fell 1,279.2% compared with a year earlier. Earnings per share were −$16.24.
The operating margin was 7.2%, 1.3 percentage points higher than a year earlier (as of 4 November 2026).
What is Concentrix's market cap?
Concentrix Corporation's market capitalisation is $1.9 B at a stock price of $30.93. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).
How is Concentrix performing?
Concentrix Corporation's latest readings are below. In its latest quarter, revenue fell 1.2% and profit fell 1,279.2% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 11 weeks running.
This describes what the data did, not a rating (as of 4 November 2026).
Will Concentrix's stock price go up?
This page does not forecast Concentrix Corporation's stock price. What it shows instead: the stock price is $30.93. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026).
Is Concentrix's profit real cash?
Yes, over the last 3 years, 199% of Concentrix Corporation's reported profit came in as cash from operations. The latest year was lower at -63%, so the trend is worth watching. In FY25, operating cash was $807 M against reported profit of −$1.3 B.
Most of that cash then goes into building new capacity. These are yearly figures (as of 4 November 2026).
Where is Concentrix in its business cycle?
Concentrix Corporation's FY25 operating margin was 6.2%, against a 5-year range of 6.1% to 10.6%: the low end of its own range, which is often where recoveries start. The latest quarter was 7.2%.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).
What could break the Concentrix story?
The main question: the share price moved −11.0% in a year while yearly earnings per share moved −648.1%. The difference came from the market paying a higher multiple.
On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).
Is Concentrix a stock worth studying right now?
What the numbers show: Concentrix Corporation's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
US stocks
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.